Company Overview
- Headquarters
- 200 Inner Belt Road, Suite 400, Somerville MA
- Website
- finchtherapeutics.com
- ho****@finchtherapeutics.com
- Phone
- (617) 229-6499
- Employees
- 42
- Founded in
- 2014
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is Finch Therapeutics
Finch Therapeutics is a biotechnology company headquartered in Somerville, Massachusetts. The company employs 42 people and reports revenue greater than $10,000. Finch Therapeutics specializes in the development of microbiome-based therapeutics. Their portfolio includes CP101, a late-stage, orally administered candidate for recurrent Clostridioides difficile infection (CDI). CP101 has demonstrated positive results in both Phase 2 randomized, placebo-controlled and open-label trials. Finch is also developing pre-clinical assets targeting ulcerative colitis, Crohn's disease, and autism spectrum disorder. The company holds a significant intellectual property portfolio, including over 70 issued U.S. and foreign patents. This estate covers both donor-derived and donor-independent microbiome therapeutics across a range of potential applications. For more information, please visit Finch Therapeutics' website at finchtherapeutics.com.
Company Leadership
Finch Therapeutics Industry Tags
Finch Therapeutics Tech Stack
Companies Similar to Finch Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Finch Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
10M | 18 | Arizona City, AZ | 1998 | |
10M | 9 | San Diego, CA | ||
10M | 6 | Campbell, CA | 2011 | |
10M | 2 | Torrington, WY | ||
10M | 1 | San Diego, CA | 2016 |